- $1.12bn
- $728.00m
- CNY12.00bn
- 76
- 98
- 70
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,015 | 15,024 | 14,576 | 12,704 | 12,002 |
Cost of Revenue | |||||
Gross Profit | 8,523 | 7,047 | 6,192 | 5,283 | 4,977 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,476 | 12,491 | 16,981 | 10,958 | 9,724 |
Operating Profit | 3,539 | 2,533 | -2,406 | 1,746 | 2,278 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3,868 | 2,899 | -2,095 | 2,031 | 2,652 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,984 | 2,143 | -2,918 | 1,469 | 2,022 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,971 | 2,103 | -2,914 | 1,484 | 1,958 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,971 | 2,103 | -2,914 | 1,484 | 1,958 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.61 | 4.65 | -0.112 | 3.3 | 4.92 |